The US Food and Drug Administration (FDA) approved the use of an algorithm that monitors the vital signs of patients, which indicate the approach of sudden death. It is, first of all, about such diseases as heart attack and pulmonary insufficiency. The algorithm is called the Wave Clinical Platform, developed by Excel Medical.
The algorithm fixes subtle deviations in the patient's medical indicators and sends out alerts about 5 hours before the deterioration of its condition. The system also tracks vital parameters in interrelationship with each other. For example, a small jump in blood pressure may not indicate something serious, but in combination with a decrease in the saturation of blood with oxygen or a decrease in the frequency of breathing, indicates a serious deterioration in the patient's condition.
Artificial intelligence is useful even in the earliest stages of the disease. Its further development will help to speed up medical research, which as a result will allow solving the problem more quickly. In some cases, AI has already proven its effectiveness in diagnosing diseases. Moreover, having established the diagnosis, he will recommend treatment options for physicians.js.src = “&version=v2.8”; 'script', 'facebook-jssdk'));